Loading clinical trials...
Loading clinical trials...
Intensive chemotherapy is associated with significant thrombocytopenia, often requiring platelet transfusion to maintain platelet counts. This investigational drug has been demonstrated to increase pl...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT02682667 · Multiple Myeloma, Lymphoma, Non-Hodgkin, and more
NCT01676805 · Hodgkin Disease, Lymphoma, Non-Hodgkin, and more
NCT05169515 · Non-Hodgkin Lymphoma
NCT07072247 · Refractory Immune-mediated Platelet Transfusion Refractoriness, Relapsed or Refractory Immune Thrombocytopenia
NCT05533775 · Mature B-Cell Non-Hodgkin Lymphoma
Pfizer Investigational Site
Phoenix, Arizona
Pfizer Investigational Site
La Jolla, California
Pfizer Investigational Site
Loma Linda, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions